HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy
- 139 Downloads
Purpose of Review
Mental health disorders, especially depression, are prevalent among people living with HIV (PLWH) and are associated with cognitive impairment (CI) among HIV-uninfected (HIV−) individuals. We conducted a comprehensive review of the link between depression and cognition among PLWH.
Studies examining depression and cognition in PLWH report high rates of current (median = 24%) and lifetime depression (42%). There is reliable evidence that depression is associated with overall CI among PLWH, and in the cognitive domains of processing speed, executive function, learning and memory, and motor function. Although few studies have examined the interaction between HIV serostatus and depression on CI, there is no evidence of a stronger association between CI and depression in PLWH compared with HIV− controls.
Depression is prevalent and reliably associated with CI in PLWH, with an overall pattern of domain-specific associations similar to that of HIV− individuals.
KeywordsHIV Depression Depressive symptoms Cognitive impairment HAND
Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH113512 (Rubin).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
- 3.Orlando M, Burnam MA, Beckman R, Morton SC, London AS, Bing EG, et al. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11(2):75–82.CrossRefPubMedGoogle Scholar
- 4.Cook JA, Burke-Miller JK, Steigman PJ, Schwartz RM, Hessol NA, Milam J, et al. Prevalence, comorbidity, and correlates of psychiatric and substance use disorders and associations with HIV risk behaviors in a multisite cohort of women living with HIV. AIDS Behav. 2018;22(10):3141–54.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Do AN, Rosenberg ES, Sullivan PS, Beer L, Strine TW, Schulden JD, et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One. 2014;9(3):e92842.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Mascolini M. Depression risk factors with HIV -- plus screening and diagnosis keys. In: The Center for AIDS Information & Advocacy; 2016. http://www.thebodypro.com/content/77778/depression-risk-factors-with-hiv--plus-screening-a.html
- 10.Slot M, Sodemann M, Gabel C, Holmskov J, Laursen T, Rodkjaer L. Factors associated with risk of depression and relevant predictors of screening for depression in clinical practice: a cross-sectional study among HIV-infected individuals in Denmark. HIV medicine. 2015;16(7):393–402.CrossRefPubMedGoogle Scholar
- 14.Marquine MJ, Flores I, Kamat R, Johnson N, Umlauf A, Letendre S, et al. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning. J Neuro-Oncol. 2018;24:549–56.Google Scholar
- 16.Poquette AJ, Moore DJ, Gouaux B, Morgan EE, Grant I, Woods SP, et al. Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test. J Int Neuropsychol Soc : JINS. 2013;19(2):155–61.CrossRefPubMedGoogle Scholar
- 33.Shimizu SM, Chow DC, Valcour V, Masaki K, Nakamoto B, Kallianpur KJ, et al. The impact of depressive symptoms on neuropsychological performance tests in HIV-infected individuals: a study of the Hawaii Aging with HIV Cohort. World journal of AIDS. 2011;1(4):139–45.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Del Guerra FB, Fonseca JL, Figueiredo VM, Ziff EB, Konkiewitz EC. Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. J Neuro-Oncol. 2013;19(4):314–27.Google Scholar
- 53.Starace F, Bartoli L, Aloisi MS, Antinori A, Narciso P, Ippolito G, et al. Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand. 2002;106(1):20–6.CrossRefPubMedGoogle Scholar
- 54.Pinheiro CA, Souza LD, Motta JV, Kelbert EF, Souza MS, Martins CS, et al. Depression and diagnosis of neurocognitive impairment in HIV-positive patients. Brazil J Med Biol Res = Revista brasileira de pesquisas medicas e biologicas. 2016;49(10):e5344.Google Scholar
- 55.Judd A, Le Prevost M, Melvin D, Arenas-Pinto A, Parrott F, Winston A, et al. Cognitive function in young persons with and without perinatal HIV in the AALPHI cohort in England: role of non-HIV-related factors. Clin Infect Dis : an official publication of the Infectious Diseases Society of America. 2016;63(10):1380–7.CrossRefGoogle Scholar
- 56.Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, et al. A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infectious Dis : an official publication of the Infectious Diseases Society of America. 2016;63(5):687–93.CrossRefGoogle Scholar
- 60.Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, et al. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neuro-Oncol. 2014;20(4):380–7.Google Scholar
- 61.Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, et al. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One. 2014;9(6):e98962.CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Harrison JD, Dochney JA, Blazekovic S, Leone F, Metzger D, Frank I, et al. The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. J Neuro-Oncol. 2017;23(4):550–7.Google Scholar
- 65.Rosenthal LS, Skolasky RL, Moxley RT, Roosa HV, Selnes OA, Eschman A, et al. A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder. J Neuro-Oncol. 2013;19(5):432–41.Google Scholar
- 69.Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neuro-Oncol. 2011;17(2):176–83.Google Scholar
- 70.Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS (London, England). 2010;24(9):1243–50.Google Scholar
- 72.Armstrong NM, Surkan PJ, Treisman GJ, Sacktor NC, Irwin MR, Teplin LA, et al. Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus. J Neuro-Oncol. 2017;23(4):558–67.Google Scholar
- 73.Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis : an official publication of the Infectious Diseases Society of America. 2015;60(3):473–80.CrossRefGoogle Scholar
- 74.Vo QT, Cox C, Li X, Jacobson LP, McKaig R, Sacktor N, et al. Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study. J Neuro-Oncol. 2013;19(1):24–31.Google Scholar
- 81.Cysique LA, Dermody N, Carr A, Brew BJ, Teesson M. The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults. J Neuro-Oncol. 2016;22(1):56–65.Google Scholar
- 83.Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33 quiz 34–57.Google Scholar
- 87.Rabkin J, Rabkin R. [Depression and HIV]. Sidahora 1997:19–22.Google Scholar
- 93.Himelhoch S, Medoff D, Maxfield J, Dihmes S, Dixon L, Robinson C, et al. Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial. AIDS Behav. 2013;17(8):2756–64.CrossRefPubMedGoogle Scholar
- 94.Himelhoch S, Mohr D, Maxfield J, Clayton S, Weber E, Medoff D, et al. Feasibility of telephone-based cognitive behavioral therapy targeting major depression among urban dwelling African-American people with co-occurring HIV. Psychol Health Med. 2011;16(2):156–65.CrossRefPubMedPubMedCentralGoogle Scholar
- 101.Baune BT, Brignone M, Larsen KG. A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2018;21(2):97–107.CrossRefPubMedGoogle Scholar